TNFR2 Human, His

Tumor Necrosis Factor Receptor Type 2 Human Recombinant, His Tag

TNFR2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 184 amino acids fragment (23-206) having a molecular weight of 24.45kDa and fused with a 4.5kDa amino-terminal hexahistidine tag.
The TNFR2 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT26947
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

TNFR2 Human, Sf9

Tumor Necrosis Factor Receptor Type 2 Human Recombinant, Sf9

TNFR2 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain (23-257 a.a.) and fused to a 6 aa His Tag at C-terminus containing a total of 241 amino acids and having a molecular mass of 25.9kDa.
TNFR2 shows multiple bands between 28-40kDa on SDS-PAGE, reducing conditions and purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT27034
Source
Sf9, Baculovirus cells.
Appearance
Sterile filtered colorless solution.

TNFR2 Mouse

Tumor Necrosis Factor Receptor Type 2 Mouse Recombinant

TNFR2 Mouse Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 236 amino acids and having a molecular mass of 25.3kDa.
The TNFR2 is purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT27126
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

TNFRSF10A Human Fc

TRAIL Receptor-1 Human Recombinant Fc

TRAIL R1 Fc Human Recombinant (24-240) produced in E.Coli is a non-glycosylated, disulfide-linked homodimer containing two polypeptide chains of 217 amino acids each and having a molecular mass of 41kDa [including tag] each chain.
TRAILR1 is fused to a 236 amino acid Fc tag at C-terminal and purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT27212
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

TNFRSF10B Human

TNF Ligand Receptor Superfamily Member 10B Human Recombinant

TNFRSF10B Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 132 amino acids and having a molecular mass of 14.8kDa.
The TNFRSF10B is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT27288
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

TNFRSF10B Human, Sf9

TNF Ligand Receptor Superfamily Member 10B Human Recombinant, Sf9

TNFRSF10B produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 394 amino acids (56-210a.a.) and having a molecular mass of 43.9kDa. (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
TNFRSF10B is expressed with a 239 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT27339
Source

Sf9, Insect cells.

Appearance
Sterile Filtered colorless solution.

TNFRSF10C Human

TRAIL Receptor-3 Human Recombinant

TNFRSF10C Human Recombinant produced in E. coli is a single, non-glycosylated polypeptide chain containing 234 amino acids (26-236 a.a) and having a molecular mass of 24.6 kDa.
TNFRSF10C is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT27405
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

TNFRSF10D Human

TRAIL Receptor-4 Human Recombinant

TNFRSF10D produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 395 amino acids (56-211a.a.) and having a molecular mass of 73.8kDa. (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
TNFRSF10D is expressed with a 239 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT27508
Source
Sf9, Baculovirus cells.
Appearance
Sterile Filtered colorless solution.

TNFRSF12A Human

TNF Ligand Receptor Superfamily Member 12A Human Recombinant

TNFRSF12A Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 53 amino acids and having a molecular mass of 5.6 KDa.
The TNFRSF12A is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT27590
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

TNFRSF12A Human, sf9

TNF Ligand Receptor Superfamily Member 12A Human Recombinant, Sf9

TNFRSF12A Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 292 amino acids (28-80a.a.) and having a molecular mass of 32.6kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). TNFRSF12A is expressed with a 239 amino acids hIgG- His tag at C-Terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT27679
Source

Sf9, Baculovirus cells.

Appearance
Sterile Filtered colorless solution.
Definition and Classification

Tumor Necrosis Factor (TNF) is a cytokine, a type of signaling protein involved in systemic inflammation and is part of the body’s immune response. TNF is primarily produced by activated macrophages, although it can also be produced by other cell types such as lymphocytes, natural killer cells, and neurons. TNF is classified into two main forms:

  • TNF-α (Tumor Necrosis Factor-alpha): The most studied form, involved in systemic inflammation and acute phase reactions.
  • TNF-β (Tumor Necrosis Factor-beta): Also known as lymphotoxin, it is produced by lymphocytes and has similar but distinct functions compared to TNF-α.
Biological Properties

Key Biological Properties:

  • Molecular Weight: TNF-α is a 17 kDa protein, while TNF-β is slightly larger.
  • Structure: TNF-α is a trimeric protein, meaning it forms a complex of three identical subunits.

Expression Patterns:

  • TNF-α: Expressed primarily by macrophages, but also by other immune cells such as T cells and natural killer cells.
  • TNF-β: Expressed by activated lymphocytes.

Tissue Distribution:

  • TNF is found in various tissues, including the spleen, liver, and adipose tissue. It is also present in the bloodstream during systemic inflammation.
Biological Functions

Primary Biological Functions:

  • Inflammation: TNF is a key mediator of inflammation, promoting the recruitment of immune cells to sites of infection or injury.
  • Cell Death: TNF can induce apoptosis (programmed cell death) in certain cells, which is crucial for controlling infections and preventing cancer.
  • Immune Response: TNF plays a role in the activation and differentiation of immune cells, enhancing the body’s ability to fight off pathogens.

Role in Immune Responses:

  • Pathogen Recognition: TNF helps in recognizing and responding to pathogens by activating immune cells and promoting the production of other cytokines.
Modes of Action

Mechanisms with Other Molecules and Cells:

  • Receptors: TNF exerts its effects by binding to two receptors, TNFR1 and TNFR2, which are present on the surface of various cells.
  • Binding Partners: TNF can interact with other cytokines and signaling molecules to amplify or modulate its effects.

Downstream Signaling Cascades:

  • NF-κB Pathway: Activation of TNFR1 leads to the activation of the NF-κB pathway, which promotes the expression of genes involved in inflammation and cell survival.
  • MAPK Pathway: TNF can also activate the MAPK pathway, leading to the production of inflammatory mediators.
Regulatory Mechanisms

Regulatory Mechanisms:

  • Transcriptional Regulation: The expression of TNF is tightly regulated at the transcriptional level by various transcription factors, including NF-κB and AP-1.
  • Post-Translational Modifications: TNF undergoes several post-translational modifications, such as glycosylation and cleavage, which can affect its activity and stability.
Applications

Biomedical Research:

  • Disease Models: TNF is used in research to study inflammatory diseases, cancer, and autoimmune disorders.

Diagnostic Tools:

  • Biomarkers: Elevated levels of TNF in the blood can serve as biomarkers for various inflammatory and autoimmune diseases.

Therapeutic Strategies:

  • Anti-TNF Therapies: Drugs that inhibit TNF, such as infliximab and etanercept, are used to treat conditions like rheumatoid arthritis, Crohn’s disease, and psoriasis.
Role in the Life Cycle

Role Throughout the Life Cycle:

  • Development: TNF is involved in embryonic development, particularly in the formation of the immune system.
  • Aging: TNF levels can increase with age, contributing to age-related inflammation and diseases.
  • Disease: Dysregulation of TNF is associated with various diseases, including chronic inflammatory conditions, cancer, and neurodegenerative disorders.
© Copyright 2024 Thebiotek. All Rights Reserved.